AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-155277189/natco-pharma-launches-cancer.html" title="Facts and information about NATCO PHARMA LAUNCHES CANCER DRUG (the company is not likely to face any litigation over the generic drug).">NATCO PHARMA LAUNCHES CANCER DRUG (the company is not likely to face any litigation over the generic drug).</a>
Close
Set up an RSS feed that alerts you when new articles from India Business Insight are available.
Frequently asked questions about RSS feeds
NATCO PHARMA LAUNCHES CANCER DRUG (the company is not likely to face any litigation over the generic drug).
(From India Business Insight)
Natco Pharma Ltd (NPL) has launched an injectible drug, Pemnat, for the treatment of lung cancer. The company is not likely to face any litigation over the …
Related articles from newspapers, magazines, journals, and more
-
- New and generic drug approvals: Anastrozole Tablet, Natco Pharma.
-
News wire article from: Chemical Business Newsbase
November 7, 2008
700+ words
-
- New and generic drug approvals: Anastrazole Oral Tablet, Natco Pharma.
-
News wire article from: Chemical Business Newsbase
June 28, 2010
700+ words
-
- New and generic drug approvals: Chloroquine Phosphate Oral Tablet, Natco...
-
News wire article from: Chemical Business Newsbase
January 21, 2011
700+ words
-
- New and generic drug approvals: Granisetron Hydrochloride Oral Tablet, Natco...
-
News wire article from: Chemical Business Newsbase
June 22, 2009
700+ words
-
- New and generic drug approvals: Trihexyphenidyl Hydrochloride Oral Tablet,...
-
News wire article from: Chemical Business Newsbase
November 17, 2010
700+ words
